CBD brands face a structural problem no other retail vertical faces so sharply: the usual growth lever is switched off. Major advertising platforms restrict or prohibit CBD, so the paid-acquisition playbook most eCommerce brands run simply is not available. That makes organic and AI visibility not one channel among several, but the channel that can actually scale — and it compounds rather than stopping the moment you stop spending.
The second constraint is what you may say. Health and disease claims are off-limits, and rules differ by country and state. Rather than a handicap, this clarifies the strategy: you win by being accurate, educational and verifiable. Published certificates of analysis, cannabinoid content, sourcing and extraction detail give an assistant hard facts to work with, which is exactly what it needs before naming a brand in a regulated category.
What actually moves the needle for CBD
- Organic and AI visibility as the primary channel, built to compound — because paid acquisition largely is not open to you.
- Published COAs and lab data structured so cannabinoid content and purity are verifiable, not just asserted.
- Strictly compliant content that avoids health and disease claims while still answering the questions buyers genuinely ask.
- Market-aware messaging, tailored to what is permitted in each country or state you sell into.
- Sourcing and extraction transparency, the credibility signals that separate serious brands from the rest.
What winning looks like
You build a durable acquisition channel that does not depend on ad platforms that may never accept you — recommended by assistants because your data is verifiable and your claims are clean, with visibility you own outright rather than rent by the click.